Suchergebnisse - "Kunz, Pamela L"

PubPharm (5)

1

Cost-Effectiveness of Initial Versus Delayed Lanreotide for Treatment of Metastatic Enteropancreatic Neuroendocrine Tumors

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2020

von Barnes, J. | Lin, J. | Gupta, D. | +3

2

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

enthalten in: The New England journal of medicine | 2017

von Strosberg, J. | El-Haddad, G. | Wolin, E. | +81

CommentIn: Nat Rev Gastroenterol Hepatol. 2017 Jun;14(6):331-332. - PMID 28293026

3

Phase II pilot study of single-agent etirinotecan pegol (NKTR-102) in bevacizumab-resistant high grade glioma

enthalten in: Journal of neuro-oncology | 2015

von Nagpal, S. | Recht, C. | Bertrand, S. | +8

4

New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors

enthalten in: Clinical advances in hematology & oncology : H&O | 2015

von Phan, A. | Kunz, P. | Reidy-Lagunes, D.

5

Everolimus causing severe hypertriglyceridemia and acute pancreatitis

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2013

von Subramaniam, S. | Zell, J. | Kunz, P.

1
[1]